Japanese researchers develop miniaturized imaging probes for intraocular use during eye surgery

To provide a better view of difficult to see tissue, Japanese researchers have miniaturized an imaging probe to fit inside a needle that can be inserted into the eye during eye surgery. The probe was used without complications in three human patients, as described in an article published in Investigative Ophthalmology & Visual Science (IOVS).

The paper, Development of a fiber-optic probe for optical coherence tomography for intraocular use, highlights two strengths of the needle-sized probe over other types of surgical instruments.

First, unlike hand-held instruments, the images via probe are generated during surgery to provide real-time information to surgeons. Second, the miniaturized probe can easily scan more of the eye's interior than microscope-based instruments.

The new technology "demonstrated the precise tissue abnormality objectively during surgery, which means the quality of surgery will become better for the patient," said author Hiroko Terasaki, MD, PhD, of Nagoya University Graduate School of Medicine.

Future work will involve improving image resolution and further shrinking of the probe to fit into even smaller needles.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New insights on protein degraders open doors to treatment for 'undruggable' diseases